Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Sampson

Showing results (21-30 of 393) with videos related to

Pageof 40
Sort By:
The American Journal of Anesthesiology|April 8, 1995
Older anesthetic agents: should they be removed from clinical use?R S Twersky, I H Sampson
Neuro-Oncology|December 15, 2010
Immunotherapy coming of age: what will it take to make it standard of care for glioblastoma?Amy B Heimberger, John H Sampson
The Medical Journal of Australia|March 19, 1977
Appendicitis presenting as a swollen thighL H Sampson, S P Pegg
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|August 1, 1993
Use of hydrolyzed cow's milk formulae for prevention of early sensitization and signs of atopy must be further documentedS Dreborg, B Björkstén, H Sampson
Current Neurology and Neuroscience Reports|April 29, 2010
Immunotherapy approaches for malignant glioma from 2007 to 2009Laura A Johnson, John H Sampson
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2011
Is cytomegalovirus a therapeutic target in glioblastoma?John H Sampson, Duane A Mitchell
Neuro-Oncology|October 31, 2015
Vaccination strategies for neuro-oncologyJohn H Sampson, Duane A Mitchell
Wiener Medizinische Wochenschrift (1946)|June 15, 1980
[Hypnosis and modified hypnotherapeutic methods. Indications and results in hospitalized and ambulatory patients]H Sampson, H Schmidbauer, D Klingler
Journal of Neuro-Oncology|August 20, 2020
Temozolomide treatment outcomes and immunotherapy efficacy in brain tumorKelly M Hotchkiss, John H Sampson
Seminars in Radiation Oncology|September 16, 2014
Recurrent malignant gliomasJohn P Kirkpatrick, John H Sampson
Pageof 40

Showing results (21-30 of 393) with videos related to

Sort By:
Pageof 40
The American Journal of Anesthesiology|April 8, 1995
Older anesthetic agents: should they be removed from clinical use?R S Twersky, I H Sampson
Neuro-Oncology|December 15, 2010
Immunotherapy coming of age: what will it take to make it standard of care for glioblastoma?Amy B Heimberger, John H Sampson
The Medical Journal of Australia|March 19, 1977
Appendicitis presenting as a swollen thighL H Sampson, S P Pegg
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|August 1, 1993
Use of hydrolyzed cow's milk formulae for prevention of early sensitization and signs of atopy must be further documentedS Dreborg, B Björkstén, H Sampson
Current Neurology and Neuroscience Reports|April 29, 2010
Immunotherapy approaches for malignant glioma from 2007 to 2009Laura A Johnson, John H Sampson
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2011
Is cytomegalovirus a therapeutic target in glioblastoma?John H Sampson, Duane A Mitchell
Neuro-Oncology|October 31, 2015
Vaccination strategies for neuro-oncologyJohn H Sampson, Duane A Mitchell
Wiener Medizinische Wochenschrift (1946)|June 15, 1980
[Hypnosis and modified hypnotherapeutic methods. Indications and results in hospitalized and ambulatory patients]H Sampson, H Schmidbauer, D Klingler
Journal of Neuro-Oncology|August 20, 2020
Temozolomide treatment outcomes and immunotherapy efficacy in brain tumorKelly M Hotchkiss, John H Sampson
Seminars in Radiation Oncology|September 16, 2014
Recurrent malignant gliomasJohn P Kirkpatrick, John H Sampson
Pageof 40